Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

APR 28, 2015 - Washington Times

A Must Read - Share

New meds help drugmakers weather strong dollar, other issues

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Because ...

Tags: New meds help drugmakers weather strong dollar, other issues,  Pfizer Latest News

APR 28, 2015 - Washington Times

A Must Read - Share

Pfizer, despite dollar and generics fight, still impresses

Cost-cutting and sales of new drugs helped Pfizer overcome a strong dollar and patent expirations to beat Wall Street projections for the first quarter, though it cut its outlook for the year, citing the unfavorable currency exchange rates. The world's second-biggest drugmaker on Tuesday said its 2015 profit forecast includes ...

Tags: Pfizer, despite dollar and generics fight, still impresses,  Pfizer Latest News

APR 28, 2015 - Yahoo! News

A Must Read - Share

Pfizer cuts full-year forecast on stronger dollar

(Reuters) - U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar. However, the drugmaker reported a better-than-expected first-quarter profit, helped by demand for its vaccines and cancer drugs. Pfizer's shares were roughly unchanged at $34.62 in premarket trade on Tuesday morning. The company, which got 60 percent of its 2014 revenue from outside the ...

Tags: Pfizer cuts full-year forecast on stronger dollar,  Pfizer Latest News

APR 28, 2015 - Yahoo! News

A Must Read - Share

Pfizer quarterly revenue falls on stronger dollar

(Reuters) - Pfizer Inc reported a 4 percent fall in quarterly revenue, hurt by a stronger dollar. Net profit rose to $2.38 billion, or 38 cents per share, for the first quarter, from $2.33 billion, or 36 cents per share, a year earlier. Excluding items, the company earned 51 cents per share. Revenue fell to $10.86 billion. (Reporting by Ankur ...

Tags: Pfizer quarterly revenue falls on stronger dollar,  Pfizer Latest News

APR 23, 2015 - Yahoo! News

A Must Read - Share

AstraZeneca, Juno latest to collaborate on immuno-oncology drugs

(Reuters) - A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells. The partnership between AstraZeneca's research and development arm MedImmune and Juno is the latest collaboration between companies intent on developing a new class of drugs known as immuno-oncology therapies, considered a breakthrough ...

Tags: AstraZeneca, Juno latest to collaborate on immuno-oncology drugs,  Pfizer Latest News